Journal article
Implications of the Extended-Release/Long-Acting Opioid REMS for Managed Care
The American journal of managed care, Vol.21(9A), pp.S177A-S187A
08/01/2015
Abstract
The intent of the Risk Evaluation and Mitigation Strategy for extended-release/long-acting (ER/LA) opioid analgesics is to reduce harm by teaching prescribers how to safely use opioid analgesics. Key concepts include appropriate selection of doses and formulations for individual patients, avoidance of drug interactions that contribute to opioid toxicity, and anticipation and management of adverse effects. Abuse-deterrent opioid formulations have the potential to reduce opiate abuse and overdose, but they create unique challenges for managed care organizations.
Details
- Title: Subtitle
- Implications of the Extended-Release/Long-Acting Opioid REMS for Managed Care
- Creators
- James B. Ray - University of Iowa
- Resource Type
- Journal article
- Publication Details
- The American journal of managed care, Vol.21(9A), pp.S177A-S187A
- Publisher
- Managed Care & Healthcare Communications Llc
- ISSN
- 1088-0224
- eISSN
- 1936-2692
- Number of pages
- 11
- Grant note
- Teva Pharmaceuticals; Teva Pharmaceutical Industries Purdue Pharma LP
- Language
- English
- Date published
- 08/01/2015
- Academic Unit
- Pharmacy Practice and Science; Internal Medicine
- Record Identifier
- 9984363458002771
Metrics
3 Record Views